Acamprosate Calcium is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Acamprosate Calcium.
Product ID | 68462-435_425d66e1-b71e-4499-8afc-9c5949e7a499 |
NDC | 68462-435 |
Product Type | Human Prescription Drug |
Proprietary Name | Acamprosate Calcium |
Generic Name | Acamprosate Calcium |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-16 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202229 |
Labeler Name | Glenmark Pharmaceuticals Inc., USA |
Substance Name | ACAMPROSATE CALCIUM |
Active Ingredient Strength | 333 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2013-07-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202229 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-16 |
Marketing Category | ANDA |
Application Number | ANDA202229 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-07-16 |
Ingredient | Strength |
---|---|
ACAMPROSATE CALCIUM | 333 mg/1 |
SPL SET ID: | 43e9ef60-2d85-4394-906b-93042fea099a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0093-5352 | Acamprosate Calcium | Acamprosate Calcium |
0378-6333 | Acamprosate Calcium | acamprosate calcium enteric-coated |
0904-7213 | Acamprosate Calcium | Acamprosate Calcium |
10135-636 | Acamprosate Calcium | Acamprosate Calcium |
42291-104 | Acamprosate Calcium | Acamprosate Calcium |
51079-241 | Acamprosate Calcium | acamprosate calcium enteric-coated |
60687-121 | Acamprosate Calcium | Acamprosate Calcium |
68382-569 | acamprosate calcium | acamprosate calcium |
68462-435 | Acamprosate Calcium | Acamprosate Calcium |
70771-1057 | acamprosate calcium | acamprosate calcium |
68151-4760 | Campral | acamprosate calcium |